Role of bradykinin in postprandial hypotension in humans.

A transient significant decrease in mean arterial blood pressure (MAP) from 107 +/- 3 to 98 +/- 3 mmHg (P < 0.05) was observed in elderly (59-69 years of age), healthy volunteers 25-30 min following ingestion of a test meal. In young volunteers (22-34 years of age), a postprandial decrease of MAP from 88 +/- 3 to 83 +/- 4 mmHg was also noted but it was not statistically significant. A 40% decrease in bradykinin (BK) content of circulatory high molecular weight kininogen had previously been observed in human subjects given the same test meal. We presently demonstrate by specific ELISA that the stable pentapeptide metabolite (1-5 BK) of BK increases from 2.5 +/- 1.0 to 11.0 +/- 2.5 pg/ml plasma (P < 0.05) in elderly volunteers and from 2.0 +/- 1.0 to 10.3 +/- 3.2 pg/ml plasma (P < 0.05) in young volunteers 3 h following food intake. This result suggests that ingestion of food stimulates BK release from kininogen in normal man. Postprandial splanchnic vasodilatation, demonstrated by a decrease of plasma half-life of intravenously administered indocyanine green (ICG), a marker of mesenteric blood flow to the liver, from 4.4 +/- 0.4 to 3.0 +/- 0.1 min (P < 0.05) in young volunteers and from 5.2 +/- 1.0 to 4.0 +/- 0.5 min (P < 0.05) in elderly volunteers, accompanied BK release. The participation of BK in this response was investigated in subjects given the BK-potentiating drug captopril prior to food intake. Postprandial decreases of ICG half-lives were not changed by this treatment in either young or elderly subjects, a result which may indicate that BK released following food intake plays no role in postprandial splanchnic vasodilatation in normal man.

[1]  M. Foss,et al.  Increased kininogen levels observed in plasma of diabetic patients are corrected by the administration of insulin. , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  A. M. Rothschild,et al.  Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  C. Imai,et al.  Effects of meal ingestion and active standing on blood pressure in patients > or = 60 years of age. , 1998, The American journal of cardiology.

[4]  Y. Ouchi,et al.  Assessment of autonomic nervous function in elderly subjects with or without postprandial hypotension. , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.

[5]  G. H. Little,et al.  Bradykinin metabolism in the liver and lung of the rat. , 1996, The Journal of surgical research.

[6]  T. Ogihara,et al.  Mechanisms mediating postprandial blood pressure reduction in young and elderly subjects. , 1996, American journal of hypertension.

[7]  R. Colman,et al.  Kininogen changes in human plasma following a test meal or insulin administration. , 1996, The American journal of physiology.

[8]  T. G. Fernandes,et al.  Changes in blood pressure control in aged rats. , 1995, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[9]  L. Johnson,et al.  Physiology of the gastrointestinal tract , 2012 .

[10]  Majima Masataka,et al.  Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo , 1993 .

[11]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[12]  B. Kaye Postprandial reduction in blood pressure in the elderly. , 1984, The New England journal of medicine.

[13]  L. Rowell,et al.  INDOCYANINE GREEN CLEARANCE AND ESTIMATED HEPATIC BLOOD FLOW DURING MILD TO MAXIMAL EXERCISE IN UPRIGHT MAN. , 1964, The Journal of clinical investigation.

[14]  J. Bollman,et al.  Studies of hepatic function with indocyanine green. , 1960, Gastroenterology.

[15]  M. Katori,et al.  Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. , 1993, Biochemical Pharmacology.

[16]  M. Katori,et al.  A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. , 1992, Japanese Journal of Pharmacology.